Jane Street Group, LLC Celldex Therapeutics, Inc. Put Options Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$32.06 - $44.56 $7.81 Million - $10.9 Million	243,600 New	243,600 $8.28 Million
Q1 2022 May 17, 2022	BUY	$27.64 - $39.32 $768,392 - $1.09 Million	27,800 Added 327.06%	36,300 $1.24 Million
Q4 2021 Feb 15, 2022	SELL	$35.68 - $56.27 $214,080 - $337,620	-6,000 Reduced 41.38%	8,500 $328,000
Q3 2021 Nov 16, 2021	SELL	$28.95 - $55.99 $634,005 - $1.23 Million	-21,900 Reduced 60.16%	14,500 $783,000
Q2 2021 Aug 16, 2021	SELL	$20.71 - $35.37 $124,260 - $212,219	-6,000 Reduced 14.15%	36,400 $1.22 Million
Q1 2021 May 18, 2021	BUY	$16.19 - $29.91 $451,701 - $834,489	27,900 Added 192.41%	42,400 $873,000
Q4 2020 Feb 17, 2021	SELL	$14.99 - $22.75 $449,700 - $682,500	-30,000 Reduced 67.42%	14,500 $254,000
Q2 2020 Aug 17, 2020	BUY	$1.61 - $13.41 $71,645 - $596,745	44,500 New	44,500 $579,000

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.2B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.